《“口腔癌：从病理生理学到新型治疗方法”特刊社论》
Editorial of Special Issue "Oral Cancer: From Pathophysiology to Novel Therapeutic Approaches".
作者信息
Vincent-Chong Vui King
机构信息
Department of Oral Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
出版信息
Biomedicines. 2023 Oct 11;11(10):2748. doi: 10.3390/biomedicines11102748.
Abstract
Oral squamous cell carcinoma (OSCC) is a heterogeneous type of malignancy that develops within the oral cavity comprising the lips, tongue, mouth floor, gums, and buccal mucosa, with more than 90% arising from the oral lining epithelium [...].
摘要
口腔鳞状细胞癌（OSCC）是一种异质性恶性肿瘤，发生于包括嘴唇、舌头、口腔底部、牙龈和颊黏膜在内的口腔内，超过90%起源于口腔内衬上皮[……]
相似文献
1
Editorial of Special Issue "Oral Cancer: From Pathophysiology to Novel Therapeutic Approaches".《“口腔癌：从病理生理学到新型治疗方法”特刊社论》
Biomedicines. 2023 Oct 11;11(10):2748. doi: 10.3390/biomedicines11102748.
2
Importance of Cardiac Rehabilitation and Mouth Opening Exercises in Oral Squamous Cell Carcinoma: A Case Report.心脏康复和张口训练在口腔鳞状细胞癌中的重要性：一例报告
Cureus. 2023 Dec 22;15(12):e50954. doi: 10.7759/cureus.50954. eCollection 2023 Dec.
3
The burden of oral malignancies in Zimbabwe 1988 to 1997: a population based study.1988年至1997年津巴布韦口腔恶性肿瘤负担：一项基于人群的研究。
Cent Afr J Med. 2006 May-Jun;52(5-6):51-5.
4
Oral squamous cell carcinoma: clinicopathological features from 346 cases from a single oral pathology service during an 8-year period.口腔鳞状细胞癌：单一口腔病理服务机构 8 年期间 346 例病例的临床病理特征。
J Appl Oral Sci. 2013 Sep-Oct;21(5):460-7. doi: 10.1590/1679-775720130317.
5
Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites.四十余年来的口腔癌：按解剖部位的流行病学、趋势、组织学和生存情况。
J Oral Pathol Med. 2010 Apr;39(4):299-305. doi: 10.1111/j.1600-0714.2009.00845.x. Epub 2009 Dec 15.
6
Squamous cell carcinomas arising from different types of oral epithelia differ in their tumor and patient characteristics and survival.源自不同类型口腔上皮的鳞状细胞癌在肿瘤、患者特征及生存率方面存在差异。
Oral Oncol. 2007 Oct;43(9):911-9. doi: 10.1016/j.oraloncology.2006.11.012. Epub 2007 Jan 25.
7
Survival-Based Biomarker Module Identification Associated with Oral Squamous Cell Carcinoma (OSCC).与口腔鳞状细胞癌（OSCC）相关的基于生存的生物标志物模块鉴定
Biology (Basel). 2021 Aug 8;10(8):760. doi: 10.3390/biology10080760.
8
Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma.经口二氧化碳激光切除T1/T2期口腔鳞状细胞癌术后结局的前瞻性评估
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Aug;112(2):180-7. doi: 10.1016/j.tripleo.2010.09.078. Epub 2011 Jan 12.
9
Epidemiology of squamous cell carcinoma of the oral cavity in Iran.伊朗口腔鳞状细胞癌的流行病学
J Craniofac Surg. 2008 Nov;19(6):1699-702. doi: 10.1097/SCS.0b013e31818c04cc.
10
Experimental oral carcinoma of the tongue and buccal mucosa: possible biologic markers linked to cancers at two anatomic sites.舌和颊黏膜的实验性口腔癌：与两个解剖部位癌症相关的潜在生物学标志物
Oral Oncol. 2000 Mar;36(2):225-35. doi: 10.1016/s1368-8375(99)00077-9.
引用本文的文献
1
Molecular mechanism and biological pathway of high-expressed RAD51 in regulating cell adhesion and potentially affecting oral squamous cell carcinoma.高表达的RAD51在调节细胞黏附及可能影响口腔鳞状细胞癌中的分子机制和生物学途径
Discov Oncol. 2025 Jul 4;16(1):1260. doi: 10.1007/s12672-025-03085-y.
2
A Narrative Review: Repurposing Metformin as a Potential Therapeutic Agent for Oral Cancer.一篇叙述性综述：重新利用二甲双胍作为口腔癌的潜在治疗药物
Cancers (Basel). 2024 Aug 29;16(17):3017. doi: 10.3390/cancers16173017.
本文引用的文献
1
Mometasone Furoate Inhibits the Progression of Head and Neck Squamous Cell Carcinoma via Regulating Protein Tyrosine Phosphatase Non-Receptor Type 11.糠酸莫米松通过调节非受体型11蛋白酪氨酸磷酸酶抑制头颈部鳞状细胞癌的进展。
Biomedicines. 2023 Sep 22;11(10):2597. doi: 10.3390/biomedicines11102597.
2
A Comprehensive Review of Natural Products as Therapeutic or Chemopreventive Agents against Head and Neck Squamous Cell Carcinoma Cells Using Preclinical Models.使用临床前模型对天然产物作为治疗或化学预防剂对抗头颈部鳞状细胞癌细胞的综合综述。
Biomedicines. 2023 Aug 23;11(9):2359. doi: 10.3390/biomedicines11092359.
3
Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, CMab-34, for Multiple Applications against Oral Carcinomas.一种新型抗CD44变体7/8单克隆抗体CMab-34的研发，用于多种口腔癌治疗应用
Biomedicines. 2023 Apr 5;11(4):1099. doi: 10.3390/biomedicines11041099.
4
IFIT2 Depletion Promotes Cancer Stem Cell-like Phenotypes in Oral Cancer.IFIT2缺失促进口腔癌中癌症干细胞样表型
Biomedicines. 2023 Mar 14;11(3):896. doi: 10.3390/biomedicines11030896.
5
Deep-Learning-Based Automated Identification and Visualization of Oral Cancer in Optical Coherence Tomography Images.基于深度学习的光学相干断层扫描图像中口腔癌的自动识别与可视化
Biomedicines. 2023 Mar 6;11(3):802. doi: 10.3390/biomedicines11030802.
6
Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer.解析端粒酶逆转录酶在头颈癌中的功能
Biomedicines. 2023 Feb 24;11(3):691. doi: 10.3390/biomedicines11030691.
7
Psychosocial Adjustment Changes and Related Factors in Postoperative Oral Cancer Patients: A Longitudinal Study.口腔癌术后患者的心理社会适应变化及相关因素：一项纵向研究。
Biomedicines. 2022 Dec 12;10(12):3231. doi: 10.3390/biomedicines10123231.
8
Lymph Node Ratio in Head and Neck Cancer with Submental Flap Reconstruction.采用颏下皮瓣重建的头颈癌患者的淋巴结比率
Biomedicines. 2022 Nov 14;10(11):2923. doi: 10.3390/biomedicines10112923.
9
T-Cell Infiltration and Immune Checkpoint Expression Increase in Oral Cavity Premalignant and Malignant Disorders.T细胞浸润和免疫检查点表达在口腔癌前病变和恶性病变中增加。
Biomedicines. 2022 Jul 30;10(8):1840. doi: 10.3390/biomedicines10081840.
10
Prognostic Role of Systemic Inflammatory Markers in Patients Undergoing Surgical Resection for Oral Squamous Cell Carcinoma.全身炎症标志物在接受手术切除的口腔鳞状细胞癌患者中的预后作用
Biomedicines. 2022 May 29;10(6):1268. doi: 10.3390/biomedicines10061268.
Zotero 插件